• 1. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 4. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

Introduction to 3-Pyridinemethanamine, 6-amino-4-methyl- (CAS No. 720660-12-8)

3-Pyridinemethanamine, 6-amino-4-methyl- (CAS No. 720660-12-8) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 6-Amino-4-methylpyridine-3-methanamine, is characterized by its unique structural features and potential biological activities. Its molecular formula is C₉H₁₂N₃, and it has a molecular weight of approximately 158.21 g/mol.

The chemical structure of 3-Pyridinemethanamine, 6-amino-4-methyl- consists of a pyridine ring with a methyl group at the 4-position, an amino group at the 6-position, and an amine functional group attached to the pyridine ring at the 3-position. This combination of functional groups imparts the compound with distinct chemical properties and reactivity, making it a valuable building block in the synthesis of more complex molecules.

In recent years, 3-Pyridinemethanamine, 6-amino-4-methyl- has been extensively studied for its potential applications in drug discovery and development. One of the key areas of interest is its role as a precursor in the synthesis of novel pharmaceutical agents. The presence of multiple functional groups allows for a wide range of chemical modifications, enabling researchers to tailor the compound's properties for specific therapeutic targets.

A notable example of its application is in the development of inhibitors for various enzymes and receptors. For instance, studies have shown that derivatives of 3-Pyridinemethanamine, 6-amino-4-methyl- can exhibit potent inhibitory activity against kinases, which are important targets in cancer therapy. Kinases play crucial roles in cell signaling pathways, and their dysregulation is often associated with the development and progression of various cancers.

Beyond its use as a synthetic intermediate, 3-Pyridinemethanamine, 6-amino-4-methyl- has also been investigated for its direct biological activities. Research has demonstrated that this compound can modulate certain cellular processes, such as apoptosis and inflammation. These findings suggest that it may have therapeutic potential in treating diseases characterized by aberrant cell death or chronic inflammation.

In addition to its pharmaceutical applications, 3-Pyridinemethanamine, 6-amino-4-methyl- has found use in other areas of scientific research. For example, it has been employed as a ligand in coordination chemistry to form complexes with metal ions. These complexes can exhibit interesting electronic and magnetic properties, making them useful in materials science and catalysis.

The synthesis of 3-Pyridinemethanamine, 6-amino-4-methyl- typically involves multi-step procedures that leverage well-established organic chemistry techniques. Common synthetic routes include the reaction of appropriate pyridine derivatives with amino acids or other nitrogen-containing reagents. The choice of synthetic method depends on factors such as yield, purity, and scalability.

To ensure the quality and purity of 3-Pyridinemethanamine, 6-amino-4-methyl-, rigorous analytical methods are employed during its production and characterization. Techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and high-performance liquid chromatography (HPLC) are commonly used to verify the compound's identity and assess its purity.

In conclusion, 3-Pyridinemethanamine, 6-amino-4-methyl- (CAS No. 720660-12-8) is a multifaceted compound with significant potential in various scientific and pharmaceutical applications. Its unique chemical structure and versatile reactivity make it an invaluable tool for researchers working in medicinal chemistry, drug discovery, and related fields. As ongoing research continues to uncover new insights into its properties and applications, this compound is likely to play an increasingly important role in advancing our understanding of biological systems and developing novel therapeutic agents.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)